Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors

Benefit from chemotherapy, surgery, or both?

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish
JournalJournal of Clinical Oncology
Volume28
Issue number35
DOIs
StatePublished - Dec 10 2010

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
Mediastinal Neoplasms
Salvage Therapy
Combined Modality Therapy
Ifosfamide
Germ Cell and Embryonal Neoplasms
Carboplatin
Etoposide
Paclitaxel
Drug Therapy
Nonseminomatous germ cell tumor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{06e0d856a9584594a4a9a3344b51b8b1,
title = "Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: Benefit from chemotherapy, surgery, or both?",
author = "Lawrence Einhorn and Rafat Abonour and Kenneth Kesler",
year = "2010",
month = "12",
day = "10",
doi = "10.1200/JCO.2010.30.4626",
language = "English",
volume = "28",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "35",

}

TY - JOUR

T1 - Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors

T2 - Benefit from chemotherapy, surgery, or both?

AU - Einhorn, Lawrence

AU - Abonour, Rafat

AU - Kesler, Kenneth

PY - 2010/12/10

Y1 - 2010/12/10

UR - http://www.scopus.com/inward/record.url?scp=79951930430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951930430&partnerID=8YFLogxK

U2 - 10.1200/JCO.2010.30.4626

DO - 10.1200/JCO.2010.30.4626

M3 - Article

VL - 28

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 35

ER -